Martin Patricia A. 4

What Happened Patricia A. Martin, a director of AN2 Therapeutics, was issued 1,192 shares on April 10, 2026 as an award/compensation (transaction code A). The filing reports an acquisition price of $0.00, reflecting shares issued in lieu of cash under the company's non-employee director compensation policy; the reported total cash value is $0. All shares vest immediately per the filing.

Key Details

• Transaction date and filing date: April 10, 2026 (Form 4 accession 0001193125-26-151626).
• Transaction type/code: Award/Grant (A). Price reported: $0.00; total cash paid: $0.
• Footnote: Shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy; all shares vest immediately.
• Shares owned after transaction: Not disclosed in the provided filing.
• Filing timeliness: No indication this Form 4 was filed late.

Context This was a compensation award to a non-employee director rather than a market purchase or sale. Such awards are common for board compensation and do not by themselves indicate insider buying or selling intent. Immediate vesting means the director has full ownership of the shares upon issuance.